International Clinical Trial: A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530367) titled 'A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Condition: Palmoplantar Pustulosis (PPP)

Intervention: Drug: Tofacitinib Drug: Imatinib Drug: tofacitinib Placebo

Recruitment Sta...